NCT04511273Unknown不适用
Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder ?
Kasr El Aini Hospital0 个研究点目标入组 80 人开始时间: 2020年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 80
- 主要终点
- Sexual function evaluation after 6 months
研究概览
简要总结
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
详细描述
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •any female with overactive bladder symptoms, urgency and urgency incontinence
排除标准
- •neurologic abnormalities
- •Weak bladder contractility
- •Diabetics
结局指标
主要结局
Sexual function evaluation after 6 months
时间窗: 6 months
Sexual function evaluation using female sexual function index FSFI
次要结局
未报告次要终点
研究者
Samer Morsy
Urology Consultant
Kasr El Aini Hospital
相似试验
Unknown
不适用
Impact of Mirabegron on Erectile Function in BPH PatientsMales With Benign Prostatic Hyperplasia SymptomsNCT04503850Kasr El Aini Hospital100
已完成
4 期
Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodinePharmacokinetics of Mirabegron and TolterodineHealthyNCT01964183Astellas Pharma Inc24
Unknown
2 期
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized StudyBPHErectile DysfunctionProstate HyperplasiaErectile AbnormalitiesProstatic NeoplasmsNCT03600766Mansoura University50
招募中
3 期
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinOveractive Bladder SyndromeNCT04023253Far Eastern Memorial Hospital120
尚未招募
3 期
The effect of Mariana on sexual function and sexual satisfaction of women in reproductive ageIRCT20190425043369N1Ardabil University of Medical Sciences60